(Please note - LinkedIn Messages are not routinely monitored) Amrit Ray, MD, MBA is passionate about solving the toughest medical challenges to bring extraordinary impact to the lives of patients and families around the world. He has over 25 years of healthcare experience ranging from physician providing patient care to Fortune 100 corporate executive, public and private company board director, and private equity advisor. He is a dedicated advocate for patients and committed to building winning, diverse teams that use scientific insights to advance R&D pipelines and drive access to medicines. Amrit is a full-time, independent board chairman, director and advisor to multiple public and private, visionary life sciences companies. Previously, he was Global President, Head of R&D, and Executive Leadership Team member at Pfizer Upjohn. He has held multiple C-suite roles at major companies, including as Chief Medical Officer and as Chief Safety Officer at Johnson & Johnson Innovative Medicines (previously Janssen), and as Chief Patient Officer at Biohaven (acquired by Pfizer, 2022). As a physician researcher, he has applied deep functional experience across R&D, medical affairs and RWE to advance pipelines, registration, launch, access and high patient impact for several transformational medicines in Neuroscience, Oncology, Immunology, Cardio-metabolism and other areas. As a business executive, he has played instrumental roles in multiple, successful corporate M&A transactions, and has experience as a Senior Advisor to Bain Capital private equity.He began his career as a hospital doctor providing patient care in Britain’s National Health Service. He is a Visiting Professor of Practice in the Faculty of Medical Sciences, Newcastle University, UK and serves on the Board of Trustees at the Hastings Center for bioethics.